Framework call-off for adalimumab (Humira) to continue existing treatments

Outcome

Awarded to ABBVIE SPAIN, S.L. (Unipersonal) on 27 October 2021 for €434,660.44. Open tenders like this one are listed below.

Place
Maresme, Catalonia, Spain
Submission deadline
Not available
Award amount
€434,660.44
Award details
ABBVIE SPAIN, S.L. (Unipersonal)
October 27, 2021
Contract period
1 year
Published
November 9, 2021
spain-placsp-aggregated

Overview

Consorci Sanitari del Maresme awarded a call-off under a framework agreement for adalimumab (Humira) to continue treatments already started. The official Catalan API lists a one-year term, estimated value EUR 478,126.48 and base budget EUR 434,660.44 excluding VAT. It names ABBVIE SPAIN, S.L. (Unipersonal) as supplier for EUR 434,660.44 excluding VAT, with one offer. The API explicitly labels 27 October 2021 at 22:00 UTC as the award date and separately records formalization on 8 November 2021 at 23:00 UTC.

Information based on the public notice

Award details

Supplier
ABBVIE SPAIN, S.L. (Unipersonal)
Award date
October 27, 2021
Award amount
€434,660.44

Tender details

Buyer
Consorci Sanitari del Maresme
Country
Spain
Procedure
Negotiated procedure without prior publication
Classification
Pharmaceutical supply · CPV 33600000 · NUTS ES51
Notice reference
8650736
Estimated value
EUR 478,126.48
Base budget excl. VAT
EUR 434,660.44
Awarded supplier
ABBVIE SPAIN, S.L. (Unipersonal)
Award amount excl. VAT
EUR 434,660.44
Award date, explicitly labelled
2021-10-27 22:00 UTC
Formalization date
2021-11-08 23:00 UTC

What to check in the tender documents

  • The public API notice does not include dosage, quantity or delivery schedule; linked supporting documents were not read.
Get started with Ziva

Original notice

Read the original description

Contracte basat de l'Acord Marc del Subministrament del medicament ADALIMUMAB (HUMIRA ®) de l'empresa ABBVIE SPAIN, SL per a la continuació de tractaments ja iniciats

Contracte basat de l'Acord Marc del Subministrament del medicament ADALIMUMAB (HUMIRA ®) de l'empresa ABBVIE SPAIN, SL per a la continuació de tractaments ja iniciats Pressupost base sense IVA: 434660.44 EUR; pressupost amb IVA: 452046.85 EUR; valor estimat: 478126.48 EUR; durada: 1 any; adjudicatari: ABBVIE SPAIN, S.L. (Unipersonal); import adjudicat sense IVA: 434660.44 EUR, amb IVA: 452046.86 EUR; data d'adjudicació: 2021-10-27T22:00:00.000Z; formalització: 2021-11-08T23:00:00.000Z; ofertes: 1.

Official source: spain-placsp-aggregated ↗